Chemical Name,Chemical ID,CAS RN,Gene Symbol,Gene ID,Interaction,Interaction Actions,Reference Count,Organism Count
1-Methyl-3-isobutylxanthine,D015056,28822-58-4,FGFR1,2260,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FGFR1 mRNA,affects^cotreatment|decreases^expression,1,1
"2,2',4,4'-tetrabromodiphenyl ether",C511295,,FGFR1,2260,"2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of FGFR1 mRNA",decreases^expression,1,1
2-methyl-4-isothiazolin-3-one,C011506,2682-20-4,FGFR2,2263,2-methyl-4-isothiazolin-3-one results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
3-nitrobenzanthrone,C117220,,FGFR2,2263,3-nitrobenzanthrone results in increased expression of FGFR2 mRNA,increases^expression,1,1
"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",C459179,,FGFR1,2260,"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR1 mRNA",affects^cotreatment|increases^expression,1,1
"4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide",C459179,,FGFR1,2260,"[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR1 mRNA",affects^cotreatment|decreases^expression,1,1
4-hydroxy-2-nonenal,C027576,29343-52-0,FGFR1,2260,4-hydroxy-2-nonenal results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
"5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one",C561052,,FGFR1,2260,"5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one results in decreased activity of FGFR1 protein",decreases^activity,1,1
"5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one",C561052,,FGFR2,2263,"5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one results in decreased activity of FGFR2 protein",decreases^activity,1,1
"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",D015123,55097-80-8,FGFR2,2263,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of FGFR2 mRNA",increases^expression,1,1
abrine,C496492,,FGFR1,2260,abrine results in increased expression of FGFR1 mRNA,increases^expression,1,1
abrine,C496492,,FGFR2,2263,abrine results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Acetaminophen,D000082,103-90-2,FGFR1,2260,Acetaminophen results in increased expression of FGFR1 mRNA,increases^expression,2,1
Acetaminophen,D000082,103-90-2,FGFR2,2263,Acetaminophen affects the expression of FGFR2 mRNA,affects^expression,1,1
Acetaminophen,D000082,103-90-2,FGFR2,2263,Acetaminophen results in increased expression of FGFR2 mRNA,increases^expression,1,1
Acetone,D000096,67-64-1,FGFR2,2263,Acetone results in increased expression of FGFR2 mRNA,increases^expression,1,1
Acrolein,D000171,107-02-8,FGFR1,2260,[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of FGFR1 mRNA,affects^cotreatment|affects^expression,1,1
Acrolein,D000171,107-02-8,FGFR1,2260,[Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of FGFR1 mRNA,affects^cotreatment|affects^expression|increases^abundance,1,1
Acrylamide,D020106,,FGFR1,2260,Acrylamide analog promotes the reaction [FGFR1 protein binds to FGFR1 protein],affects^binding|increases^reaction,1,1
Aflatoxin B1,D016604,1162-65-8,FGFR2,2263,Aflatoxin B1 results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
aflatoxin B2,C029753,22040-96-6,FGFR1,2260,aflatoxin B2 results in decreased methylation of FGFR1 intron,decreases^methylation,1,1
Air Pollutants,D000393,,FGFR1,2260,[Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of FGFR1 mRNA,affects^cotreatment|affects^expression|increases^abundance,1,1
Air Pollutants,D000393,,FGFR1,2260,[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of FGFR1 mRNA,increases^abundance|increases^expression,1,1
Air Pollutants,D000393,,FGFR2,2263,[Air Pollutants results in increased abundance of Particulate Matter analog] which results in decreased expression of FGFR2 mRNA,decreases^expression|increases^abundance,1,1
Air Pollutants,D000393,,FGFR2,2263,[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of FGFR2 mRNA,decreases^expression|increases^abundance,1,1
Air Pollutants,D000393,,FGFR2,2263,[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased methylation of FGFR2 gene,decreases^methylation|increases^abundance,1,1
Air Pollutants,D000393,,FGFR2,2263,[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of FGFR2 mRNA,increases^abundance|increases^expression,1,1
alpha-pinene,C005451,80-56-8,FGFR1,2260,[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of FGFR1 mRNA,affects^cotreatment|affects^expression,1,1
alpha-pinene,C005451,80-56-8,FGFR1,2260,[Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of FGFR1 mRNA,affects^cotreatment|affects^expression|increases^abundance,1,1
Antirheumatic Agents,D018501,,FGFR1,2260,Antirheumatic Agents results in increased expression of FGFR1 mRNA,increases^expression,1,1
aristolochic acid I,C000228,313-67-7,FGFR2,2263,aristolochic acid I results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Arsenic Trioxide,D000077237,1327-53-3,FGFR1,2260,Arsenic Trioxide promotes the reaction [PD 173074 results in decreased expression of FGFR1 protein],decreases^expression|increases^reaction,1,1
Arsenic Trioxide,D000077237,1327-53-3,FGFR1,2260,Arsenic Trioxide results in decreased expression of FGFR1 mRNA,decreases^expression,2,1
Arsenic Trioxide,D000077237,1327-53-3,FGFR1,2260,Arsenic Trioxide results in decreased expression of FGFR1 protein,decreases^expression,1,1
Arsenic Trioxide,D000077237,1327-53-3,FGFR1,2260,Arsenic Trioxide results in decreased phosphorylation of FGFR1 protein mutant form,decreases^phosphorylation,1,1
Arsenic Trioxide,D000077237,1327-53-3,FGFR1,2260,Arsenic Trioxide results in increased expression of FGFR1 mRNA,increases^expression,2,1
Arsenic Trioxide,D000077237,1327-53-3,FGFR1,2260,FGFR1 protein results in decreased susceptibility to Arsenic Trioxide,decreases^response to substance,1,1
Arsenic Trioxide,D000077237,1327-53-3,FGFR1,2260,PD 173074 promotes the reaction [Arsenic Trioxide results in decreased expression of FGFR1 protein],decreases^expression|increases^reaction,1,1
Arsenic Trioxide,D000077237,1327-53-3,FGFR2,2263,Arsenic Trioxide results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
arsenite,C015001,15502-74-6,FGFR2,2263,arsenite results in increased methylation of FGFR2 promoter,increases^methylation,1,1
"Asbestos, Crocidolite",D017638,12001-28-4,FGFR1,2260,"Asbestos, Crocidolite results in decreased expression of FGFR1 mRNA",decreases^expression,1,1
"Asbestos, Crocidolite",D017638,12001-28-4,FGFR2,2263,"Asbestos, Crocidolite results in decreased expression of FGFR2 mRNA",decreases^expression,1,1
asparanin A,C540172,,FGFR2,2263,asparanin A results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
AZD4547,C572463,,FGFR2,2263,AZD4547 results in decreased phosphorylation of FGFR2 protein,decreases^phosphorylation,1,1
Benzo(a)pyrene,D001564,50-32-8,FGFR1,2260,Benzo(a)pyrene results in decreased expression of FGFR1 mRNA,decreases^expression,2,1
Benzo(a)pyrene,D001564,50-32-8,FGFR1,2260,Benzo(a)pyrene results in increased expression of FGFR1 mRNA,increases^expression,1,1
Benzo(a)pyrene,D001564,50-32-8,FGFR1,2260,Benzo(a)pyrene results in increased methylation of FGFR1 5' UTR,increases^methylation,1,1
Benzo(a)pyrene,D001564,50-32-8,FGFR1,2260,Benzo(a)pyrene results in increased methylation of FGFR1 promoter,increases^methylation,1,1
Benzo(a)pyrene,D001564,50-32-8,FGFR1,2260,Benzo(a)pyrene results in increased mutagenesis of FGFR1 gene,increases^mutagenesis,1,1
Benzo(a)pyrene,D001564,50-32-8,FGFR2,2263,Benzo(a)pyrene affects the methylation of FGFR2 5' UTR,affects^methylation,1,1
Benzo(a)pyrene,D001564,50-32-8,FGFR2,2263,Benzo(a)pyrene results in increased methylation of FGFR2 exon,increases^methylation,1,1
Benzo(a)pyrene,D001564,50-32-8,FGFR2,2263,Benzo(a)pyrene results in increased methylation of FGFR2 promoter,increases^methylation,1,1
beta-lapachone,C014638,,FGFR1,2260,beta-lapachone results in increased expression of FGFR1 mRNA,increases^expression,1,1
bifenthrin,C099952,82657-04-3,FGFR2,2263,bifenthrin binds to FGFR2 protein,affects^binding,1,1
bisphenol A,C006780,80-05-7,FGFR1,2260,bisphenol A results in decreased methylation of FGFR1 gene,decreases^methylation,1,1
bisphenol A,C006780,80-05-7,FGFR1,2260,bisphenol A results in increased expression of FGFR1 mRNA,increases^expression,1,1
bisphenol A,C006780,80-05-7,FGFR2,2263,bisphenol A affects the expression of FGFR2 mRNA,affects^expression,1,1
bisphenol S,C543008,,FGFR1,2260,[bisphenol S co-treated with Fulvestrant] results in decreased methylation of FGFR1 gene,affects^cotreatment|decreases^methylation,1,1
bisphenol S,C543008,,FGFR1,2260,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FGFR1 mRNA,affects^cotreatment|decreases^expression,1,1
BXL628,C487049,,FGFR2,2263,BXL628 inhibits the reaction [FGF7 protein results in increased phosphorylation of FGFR2 protein],decreases^reaction|increases^phosphorylation,1,1
Cadmium,D002104,7440-43-9,FGFR1,2260,Cadmium results in increased expression of FGFR1 mRNA,increases^expression,1,1
Cadmium,D002104,7440-43-9,FGFR2,2263,Cadmium results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Cadmium Chloride,D019256,10108-64-2,FGFR1,2260,Cadmium Chloride results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Calcitriol,D002117,32222-06-3,FGFR1,2260,Calcitriol results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Calcitriol,D002117,32222-06-3,FGFR2,2263,Calcitriol results in increased expression of FGFR2 mRNA,increases^expression,1,1
Calcitriol,D002117,32222-06-3,FGFR2,2263,Calcitriol results in increased expression of FGFR2 protein,increases^expression,1,1
Calcitriol,D002117,32222-06-3,FGFR2,2263,[Testosterone co-treated with Calcitriol] results in increased expression of FGFR2 mRNA,affects^cotreatment|increases^expression,1,1
Carbamazepine,D002220,298-46-4,FGFR1,2260,Carbamazepine affects the expression of FGFR1 mRNA,affects^expression,1,1
CGP 52608,C092451,87958-67-6,FGFR1,2260,CGP 52608 promotes the reaction [RORA protein binds to FGFR1 gene],affects^binding|increases^reaction,1,1
CGP 52608,C092451,87958-67-6,FGFR2,2263,CGP 52608 promotes the reaction [RORA protein binds to FGFR2 gene],affects^binding|increases^reaction,1,1
Chelating Agents,D002614,,FGFR1,2260,[Chelating Agents binds to Copper] which affects the expression of FGFR1 mRNA,affects^binding|affects^expression,1,1
Chelating Agents,D002614,,FGFR2,2263,[Chelating Agents binds to Copper] which results in decreased expression of FGFR2 mRNA,affects^binding|decreases^expression,1,1
Chlorpromazine,D002746,50-53-3,FGFR1,2260,Chlorpromazine analog results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
cinnamaldehyde,C012843,,FGFR2,2263,cinnamaldehyde results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Cisplatin,D002945,15663-27-1,FGFR1,2260,Cisplatin promotes the reaction [jinfukang results in decreased expression of FGFR1 mRNA],decreases^expression|increases^reaction,1,1
Cisplatin,D002945,15663-27-1,FGFR1,2260,Cisplatin results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Cisplatin,D002945,15663-27-1,FGFR1,2260,jinfukang promotes the reaction [Cisplatin results in decreased expression of FGFR1 mRNA],decreases^expression|increases^reaction,1,1
Cisplatin,D002945,15663-27-1,FGFR2,2263,Cisplatin results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Cisplatin,D002945,15663-27-1,FGFR2,2263,FGFR2 protein affects the susceptibility to Cisplatin,affects^response to substance,1,1
Colforsin,D005576,138605-00-2,FGFR1,2260,Colforsin results in increased expression of FGFR1 mRNA,increases^expression,1,1
Colforsin,D005576,138605-00-2,FGFR2,2263,Colforsin results in increased expression of FGFR2 mRNA,increases^expression,1,1
Copper,D003300,7440-50-8,FGFR1,2260,[Chelating Agents binds to Copper] which affects the expression of FGFR1 mRNA,affects^binding|affects^expression,1,1
Copper,D003300,7440-50-8,FGFR2,2263,[Chelating Agents binds to Copper] which results in decreased expression of FGFR2 mRNA,affects^binding|decreases^expression,1,1
cordycepin,C058120,73-03-0,FGFR2,2263,cordycepin binds to and results in decreased phosphorylation of FGFR2 protein,affects^binding|decreases^phosphorylation,1,1
Coumestrol,D003375,479-13-0,FGFR1,2260,Coumestrol results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Crizotinib,D000077547,,FGFR1,2260,[PD 173074 results in decreased activity of FGFR1 protein] inhibits the reaction [[Crizotinib results in decreased phosphorylation of MET protein] which results in increased expression of HGF protein],decreases^activity|decreases^phosphorylation|decreases^reaction|increases^expression,1,1
cupric chloride,C029892,7447-39-4,FGFR1,2260,cupric chloride affects the expression of FGFR1 mRNA,affects^expression,1,1
Curcumin,D003474,458-37-7,FGFR2,2263,Curcumin results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Cyclosporine,D016572,59865-13-3,FGFR1,2260,Cyclosporine results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Cyclosporine,D016572,59865-13-3,FGFR2,2263,Cyclosporine results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
cyhalothrin,C037304,68085-85-8,FGFR2,2263,cyhalothrin binds to FGFR2 protein,affects^binding,1,1
Decitabine,D000077209,2353-33-5,FGFR1,2260,Decitabine results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Dexamethasone,D003907,50-02-2,FGFR1,2260,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FGFR1 mRNA,affects^cotreatment|decreases^expression,1,1
Diazepam,D003975,439-14-5,FGFR2,2263,Diazepam results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Diclofenac,D004008,15307-86-5,FGFR1,2260,Diclofenac affects the expression of FGFR1 mRNA,affects^expression,1,1
Diethylhexyl Phthalate,D004051,117-81-7,FGFR1,2260,Diethylhexyl Phthalate results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
dimethylarsinous acid,C472511,,FGFR1,2260,dimethylarsinous acid results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
dorsomorphin,C516138,,FGFR1,2260,"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR1 mRNA",affects^cotreatment|increases^expression,1,1
dorsomorphin,C516138,,FGFR1,2260,"[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR1 mRNA",affects^cotreatment|decreases^expression,1,1
Doxorubicin,D004317,23214-92-8,FGFR1,2260,Doxorubicin results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Doxorubicin,D004317,23214-92-8,FGFR2,2263,Doxorubicin results in increased expression of FGFR2 mRNA,increases^expression,1,1
"Drugs, Chinese Herbal",D004365,,FGFR1,2260,"Drugs, Chinese Herbal inhibits the reaction [FGF2 protein results in increased phosphorylation of FGFR1 protein]",decreases^reaction|increases^phosphorylation,1,1
"Drugs, Chinese Herbal",D004365,,FGFR1,2260,"Drugs, Chinese Herbal results in decreased activity of FGFR1 protein",decreases^activity,1,1
Ellagic Acid,D004610,476-66-4,FGFR1,2260,Ellagic Acid results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
entinostat,C118739,,FGFR1,2260,entinostat results in increased expression of FGFR1 mRNA,increases^expression,1,1
entinostat,C118739,,FGFR1,2260,"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGFR1 mRNA",affects^cotreatment|increases^expression,1,1
Estradiol,D004958,50-28-2,FGFR1,2260,Estradiol results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Estradiol,D004958,50-28-2,FGFR2,2263,ESR2 protein affects the reaction [Estradiol results in decreased expression of FGFR2 mRNA],affects^reaction|decreases^expression,1,1
Estradiol,D004958,50-28-2,FGFR2,2263,Estradiol affects the expression of FGFR2 mRNA,affects^expression,1,1
Estradiol,D004958,50-28-2,FGFR2,2263,[Estradiol co-treated with Progesterone] results in decreased expression of FGFR2 mRNA,affects^cotreatment|decreases^expression,1,1
Estradiol,D004958,50-28-2,FGFR2,2263,Estradiol results in decreased expression of FGFR2 mRNA,decreases^expression,2,1
Estradiol,D004958,50-28-2,FGFR2,2263,Estradiol results in increased expression of FGFR2 mRNA alternative form,increases^expression,1,1
Estradiol,D004958,50-28-2,FGFR2,2263,Estradiol results in increased expression of FGFR2 protein alternative form,increases^expression,1,1
Ethanol,D000431,64-17-5,FGFR2,2263,Ethanol results in increased expression of FGFR2 mRNA,increases^expression,1,1
Ethinyl Estradiol,D004997,57-63-6,FGFR2,2263,Ethinyl Estradiol affects the expression of FGFR2 mRNA,affects^expression,2,1
Ethinyl Estradiol,D004997,57-63-6,FGFR2,2263,Ethinyl Estradiol results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
"ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate",C560274,,FGFR1,2260,"ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate analog inhibits the reaction [FGF2 protein results in increased phosphorylation of FGFR1 protein]",decreases^reaction|increases^phosphorylation,1,1
"ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate",C560274,,FGFR1,2260,"ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate analog results in decreased activity of FGFR1 protein",decreases^activity,1,1
"ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate",C560274,,FGFR1,2260,"ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate inhibits the reaction [FGF2 protein results in increased phosphorylation of FGFR1 protein]",decreases^reaction|increases^phosphorylation,1,1
"ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate",C560274,,FGFR1,2260,"ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate results in decreased activity of FGFR1 protein",decreases^activity,1,1
ethyl caffeate,C032773,102-37-4,FGFR1,2260,ethyl caffeate affects the expression of FGFR1 protein,affects^expression,1,1
evodiamine,C049639,5956-87-6,FGFR2,2263,evodiamine results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Fluorouracil,D005472,51-21-8,FGFR2,2263,FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Fluorouracil],decreases^reaction|decreases^response to substance,1,1
Fluorouracil,D005472,51-21-8,FGFR2,2263,FGFR2 protein alternative form inhibits the reaction [FGF7 protein results in decreased susceptibility to Fluorouracil],decreases^reaction|decreases^response to substance,1,1
fluvalinate,C034227,79472-91-6,FGFR2,2263,fluvalinate binds to FGFR2 protein,affects^binding,1,1
Folic Acid,D005492,59-30-3,FGFR1,2260,Folic Acid results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Formaldehyde,D005557,50-00-0,FGFR1,2260,Formaldehyde results in increased expression of FGFR1 mRNA,increases^expression,1,1
Fulvestrant,D000077267,129453-61-8,FGFR1,2260,[bisphenol S co-treated with Fulvestrant] results in decreased methylation of FGFR1 gene,affects^cotreatment|decreases^methylation,1,1
Genistein,D019833,446-72-0,FGFR2,2263,ESR2 promotes the reaction [Genistein results in increased expression of FGFR2 protein],increases^expression|increases^reaction,1,1
Genistein,D019833,446-72-0,FGFR2,2263,Genistein results in decreased expression of FGFR2 mRNA,decreases^expression,2,1
Genistein,D019833,446-72-0,FGFR2,2263,Genistein results in increased expression of FGFR2 protein,increases^expression,1,1
Heparan Sulfate Proteoglycans,D019812,,FGFR1,2260,[Heparan Sulfate Proteoglycans binds to FGF2 protein binds to FGFR1 protein] which binds to ANOS1 protein,affects^binding,1,1
Heparan Sulfate Proteoglycans,D019812,,FGFR1,2260,Heparan Sulfate Proteoglycans promotes the reaction [FGF1 protein binds to and results in increased activity of FGFR1 protein],affects^binding|increases^activity|increases^reaction,1,1
Heparin,D006493,9005-49-6,FGFR1,2260,Heparin binds to FGFR1 protein binds to FGF2 protein,affects^binding,1,1
Heparin,D006493,9005-49-6,FGFR2,2263,[Heparin analog binds to FGFR2 protein alternative form] which binds to and results in increased activity of FGF1 protein,affects^binding|increases^activity,1,1
Heparin,D006493,9005-49-6,FGFR2,2263,Heparin promotes the reaction [FGF10 protein binds to FGFR2 protein],affects^binding|increases^reaction,1,1
Heparitin Sulfate,D006497,9050-30-0,FGFR1,2260,FGF1 protein binds to Heparitin Sulfate binds to FGFR1 protein,affects^binding,1,1
Heparitin Sulfate,D006497,9050-30-0,FGFR2,2263,Heparitin Sulfate analog results in decreased activity of FGFR2 protein mutant form,decreases^activity,1,1
Hydrogen Peroxide,D006861,7722-84-1,FGFR1,2260,Hydrogen Peroxide promotes the reaction [FGF2 protein binds to FGFR1 protein],affects^binding|increases^reaction,1,1
Hydrogen Peroxide,D006861,7722-84-1,FGFR1,2260,Hydrogen Peroxide results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Hydrogen Peroxide,D006861,7722-84-1,FGFR2,2263,Hydrogen Peroxide affects the expression of FGFR2 mRNA,affects^expression,1,1
Immunotoxins,D000922,,FGFR1,2260,Immunotoxins binds to and results in decreased activity of FGFR1 protein,affects^binding|decreases^activity,1,1
Indomethacin,D007213,53-86-1,FGFR1,2260,[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FGFR1 mRNA,affects^cotreatment|decreases^expression,1,1
Isotretinoin,D015474,4759-48-2,FGFR1,2260,Isotretinoin results in increased expression of FGFR1 mRNA,increases^expression,1,1
jinfukang,C544151,,FGFR1,2260,Cisplatin promotes the reaction [jinfukang results in decreased expression of FGFR1 mRNA],decreases^expression|increases^reaction,1,1
jinfukang,C544151,,FGFR1,2260,jinfukang promotes the reaction [Cisplatin results in decreased expression of FGFR1 mRNA],decreases^expression|increases^reaction,1,1
(+)-JQ1 compound,C561695,,FGFR1,2260,(+)-JQ1 compound results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
lead acetate,C008261,301-04-2,FGFR1,2260,[lead acetate co-treated with zinc protoporphyrin] results in increased expression of FGFR1 mRNA,affects^cotreatment|increases^expression,1,1
Lenalidomide,D000077269,191732-72-6,FGFR1,2260,Lenalidomide affects the expression of FGFR1 mRNA,affects^expression,1,1
Lenalidomide,D000077269,191732-72-6,FGFR2,2263,Lenalidomide results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Lenalidomide,D000077269,191732-72-6,FGFR2,2263,Lenalidomide results in decreased expression of FGFR2 protein,decreases^expression,1,1
LG 100815,C533894,,FGFR2,2263,LG 100815 results in increased expression of FGFR2 mRNA,increases^expression,1,1
Magnetite Nanoparticles,D058185,,FGFR2,2263,Magnetite Nanoparticles results in decreased methylation of FGFR2 promoter,decreases^methylation,1,1
Malathion,D008294,121-75-5,FGFR1,2260,Malathion results in increased expression of FGFR1 mRNA,increases^expression,1,1
Manganese,D008345,7439-96-5,FGFR1,2260,[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FGFR1 mRNA,decreases^expression|increases^abundance,1,1
manganese chloride,C025340,7773-01-5,FGFR1,2260,[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FGFR1 mRNA,decreases^expression|increases^abundance,1,1
mercuric bromide,C042720,7789-47-1,FGFR2,2263,mercuric bromide results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
methacrylaldehyde,C039175,78-85-3,FGFR1,2260,[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of FGFR1 mRNA,affects^cotreatment|affects^expression,1,1
methacrylaldehyde,C039175,78-85-3,FGFR1,2260,[Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of FGFR1 mRNA,affects^cotreatment|affects^expression|increases^abundance,1,1
Methotrexate,D008727,59-05-2,FGFR1,2260,FGFR1 protein affects the susceptibility to Methotrexate,affects^response to substance,1,1
methyleugenol,C005223,93-15-2,FGFR2,2263,methyleugenol results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
methylmercuric chloride,C004925,115-09-3,FGFR1,2260,methylmercuric chloride results in increased expression of FGFR1 mRNA,increases^expression,1,1
methylmercuric chloride,C004925,115-09-3,FGFR2,2263,methylmercuric chloride results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
mono-(2-ethylhexyl)phthalate,C016599,4376-20-9,FGFR1,2260,mono-(2-ethylhexyl)phthalate results in increased expression of FGFR1 mRNA,increases^expression,1,1
monomethylarsonous acid,C406082,,FGFR1,2260,monomethylarsonous acid results in increased expression of FGFR1 mRNA,increases^expression,1,1
"Nanotubes, Carbon",D037742,,FGFR2,2263,"Nanotubes, Carbon results in increased expression of FGFR2 mRNA",increases^expression,1,1
napabucasin,C000621033,,FGFR2,2263,napabucasin results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Naphthyridines,D009287,,FGFR1,2260,Naphthyridines analog results in decreased activity of FGFR1 protein,decreases^activity,1,1
N-benzyloxycarbonylprolylprolinal,C038541,86925-97-5,FGFR1,2260,N-benzyloxycarbonylprolylprolinal results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
neferine,C057222,2292-16-2,FGFR2,2263,FGFR2 protein inhibits the reaction [neferine results in decreased expression of CCND1 protein],decreases^expression|decreases^reaction,1,1
neferine,C057222,2292-16-2,FGFR2,2263,FGFR2 protein inhibits the reaction [neferine results in decreased expression of MMP2 protein],decreases^expression|decreases^reaction,1,1
neferine,C057222,2292-16-2,FGFR2,2263,FGFR2 protein inhibits the reaction [neferine results in decreased expression of MMP9 protein],decreases^expression|decreases^reaction,1,1
neferine,C057222,2292-16-2,FGFR2,2263,FGFR2 protein inhibits the reaction [neferine results in decreased expression of VIM protein],decreases^expression|decreases^reaction,1,1
neferine,C057222,2292-16-2,FGFR2,2263,FGFR2 protein inhibits the reaction [neferine results in decreased phosphorylation of AKT1 protein],decreases^phosphorylation|decreases^reaction,1,1
neferine,C057222,2292-16-2,FGFR2,2263,FGFR2 protein inhibits the reaction [neferine results in decreased phosphorylation of MAPK1 protein],decreases^phosphorylation|decreases^reaction,1,1
neferine,C057222,2292-16-2,FGFR2,2263,FGFR2 protein inhibits the reaction [neferine results in decreased phosphorylation of MAPK3 protein],decreases^phosphorylation|decreases^reaction,1,1
neferine,C057222,2292-16-2,FGFR2,2263,FGFR2 protein inhibits the reaction [neferine results in decreased phosphorylation of PIK3R1 protein],decreases^phosphorylation|decreases^reaction,1,1
neferine,C057222,2292-16-2,FGFR2,2263,FGFR2 protein inhibits the reaction [neferine results in increased cleavage of CASP3 protein],decreases^reaction|increases^cleavage,1,1
neferine,C057222,2292-16-2,FGFR2,2263,FGFR2 protein inhibits the reaction [neferine results in increased cleavage of CASP9 protein],decreases^reaction|increases^cleavage,1,1
neferine,C057222,2292-16-2,FGFR2,2263,FGFR2 protein inhibits the reaction [neferine results in increased expression of ARPC5 protein],decreases^reaction|increases^expression,1,1
Nickel,D009532,7440-02-0,FGFR2,2263,Nickel results in decreased expression of FGFR2 mRNA,decreases^expression,2,1
nickel sulfate,C029938,7786-81-4,FGFR2,2263,nickel sulfate results in increased expression of FGFR2 protein,increases^expression,1,1
"octa-2,4,6-trienoic acid",C062198,5205-32-3,FGFR2,2263,"octa-2,4,6-trienoic acid results in increased expression of FGFR2 mRNA",increases^expression,1,1
Okadaic Acid,D019319,78111-17-8,FGFR1,2260,Okadaic Acid results in increased expression of FGFR1 mRNA,increases^expression,1,1
Okadaic Acid,D019319,78111-17-8,FGFR2,2263,Okadaic Acid results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
ON 01910,C507134,,FGFR2,2263,ON 01910 results in decreased phosphorylation of FGFR2 protein,decreases^phosphorylation,1,1
orantinib,C412603,210644-62-5,FGFR1,2260,orantinib results in decreased phosphorylation of and results in decreased activity of FGFR1 protein,decreases^activity|decreases^phosphorylation,1,1
Oxaliplatin,D000077150,,FGFR2,2263,Oxaliplatin results in increased expression of FGFR2 mRNA,increases^expression,1,1
Ozone,D010126,10028-15-6,FGFR1,2260,[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of FGFR1 mRNA,affects^cotreatment|affects^expression,1,1
Ozone,D010126,10028-15-6,FGFR1,2260,[Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of FGFR1 mRNA,affects^cotreatment|affects^expression|increases^abundance,1,1
Ozone,D010126,10028-15-6,FGFR1,2260,[Volatile Organic Compounds co-treated with Ozone] affects the expression of FGFR1 mRNA,affects^cotreatment|affects^expression,1,1
Paraoxon,D010261,311-45-5,FGFR1,2260,Paraoxon results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Particulate Matter,D052638,,FGFR1,2260,[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of FGFR1 mRNA,increases^abundance|increases^expression,1,1
Particulate Matter,D052638,,FGFR1,2260,Particulate Matter affects the expression of FGFR1 mRNA,affects^expression,1,1
Particulate Matter,D052638,,FGFR1,2260,Particulate Matter results in increased expression of FGFR1 mRNA,increases^expression,1,1
Particulate Matter,D052638,,FGFR2,2263,[Air Pollutants results in increased abundance of Particulate Matter analog] which results in decreased expression of FGFR2 mRNA,decreases^expression|increases^abundance,1,1
Particulate Matter,D052638,,FGFR2,2263,[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of FGFR2 mRNA,decreases^expression|increases^abundance,1,1
Particulate Matter,D052638,,FGFR2,2263,[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased methylation of FGFR2 gene,decreases^methylation|increases^abundance,1,1
Particulate Matter,D052638,,FGFR2,2263,[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of FGFR2 mRNA,increases^abundance|increases^expression,1,1
Particulate Matter,D052638,,FGFR2,2263,Particulate Matter results in decreased expression of FGFR2 mRNA,decreases^expression,2,1
Particulate Matter,D052638,,FGFR2,2263,[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of FGFR2 mRNA,increases^abundance|increases^expression,1,1
PD 166866,C113399,,FGFR1,2260,PD 166866 results in decreased activity of FGFR1 protein,decreases^activity,1,1
PD 173074,C115711,,FGFR1,2260,Arsenic Trioxide promotes the reaction [PD 173074 results in decreased expression of FGFR1 protein],decreases^expression|increases^reaction,1,1
PD 173074,C115711,,FGFR1,2260,PD 173074 promotes the reaction [Arsenic Trioxide results in decreased expression of FGFR1 protein],decreases^expression|increases^reaction,1,1
PD 173074,C115711,,FGFR1,2260,PD 173074 results in decreased activity of FGFR1 protein,decreases^activity,2,1
PD 173074,C115711,,FGFR1,2260,[PD 173074 results in decreased activity of FGFR1 protein] inhibits the reaction [[Crizotinib results in decreased phosphorylation of MET protein] which results in increased expression of HGF protein],decreases^activity|decreases^phosphorylation|decreases^reaction|increases^expression,1,1
PD 173074,C115711,,FGFR1,2260,PD 173074 results in decreased expression of FGFR1 protein,decreases^expression,1,1
perfluorodecanesulfonic acid,C000720114,,FGFR2,2263,perfluorodecanesulfonic acid results in increased expression of FGFR2 mRNA,increases^expression,1,1
perfluorooctane sulfonic acid,C076994,1763-23-1,FGFR2,2263,perfluorooctane sulfonic acid results in increased expression of FGFR2 mRNA,increases^expression,1,1
perfluorooctanoic acid,C023036,335-67-1,FGFR2,2263,perfluorooctanoic acid results in increased expression of FGFR2 mRNA,increases^expression,1,1
Permethrin,D026023,52645-53-1,FGFR2,2263,Permethrin results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Phenytoin,D010672,57-41-0,FGFR2,2263,Phenytoin results in increased expression of FGFR2 mRNA,increases^expression,1,1
Phenytoin,D010672,57-41-0,FGFR2,2263,Phenytoin results in increased expression of FGFR2 protein,increases^expression,1,1
Phosphates,D010710,,FGFR1,2260,FGFR1 protein alternative form promotes the reaction [FGF23 protein results in decreased uptake of Phosphates],decreases^uptake|increases^reaction,1,1
piperine,C008922,7780-20-3,FGFR1,2260,piperine binds to FGFR1 protein,affects^binding,1,1
pirinixic acid,C006253,50892-23-4,FGFR2,2263,[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FGFR2 mRNA,affects^binding|increases^activity|increases^expression,1,1
pomalidomide,C467566,,FGFR1,2260,pomalidomide results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
ponatinib,C545373,,FGFR1,2260,ponatinib analog results in decreased activity of FGFR1 protein,decreases^activity,1,1
ponatinib,C545373,,FGFR1,2260,ponatinib results in decreased activity of FGFR1 protein,decreases^activity,2,1
ponatinib,C545373,,FGFR1,2260,ponatinib results in decreased activity of FGFR1 protein mutant form,decreases^activity,1,1
ponatinib,C545373,,FGFR1,2260,ponatinib results in decreased phosphorylation of FGFR1 protein mutant form,decreases^phosphorylation,2,1
ponatinib,C545373,,FGFR2,2263,ponatinib analog results in decreased activity of FGFR2 protein,decreases^activity,1,1
ponatinib,C545373,,FGFR2,2263,ponatinib results in decreased activity of FGFR2 protein,decreases^activity,1,1
ponatinib,C545373,,FGFR2,2263,ponatinib results in decreased activity of FGFR2 protein mutant form,decreases^activity,1,1
Progesterone,D011374,57-83-0,FGFR2,2263,[Estradiol co-treated with Progesterone] results in decreased expression of FGFR2 mRNA,affects^cotreatment|decreases^expression,1,1
Raloxifene Hydrochloride,D020849,,FGFR2,2263,[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of FGFR2 mRNA,affects^cotreatment|decreases^expression,1,1
Resveratrol,D000077185,,FGFR1,2260,Resveratrol results in increased expression of FGFR1 mRNA,increases^expression,1,1
salinomycin,C010327,,FGFR1,2260,salinomycin results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Silicon Dioxide,D012822,7631-86-9,FGFR2,2263,Silicon Dioxide analog results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Silicon Dioxide,D012822,7631-86-9,FGFR2,2263,Silicon Dioxide results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Silver Compounds,D018030,,FGFR2,2263,Silver Compounds results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Smoke,D012906,,FGFR2,2263,Smoke results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
sodium arsenite,C017947,13768-07-5,FGFR1,2260,sodium arsenite results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
sodium arsenite,C017947,13768-07-5,FGFR2,2263,sodium arsenite results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
sodium bichromate,C016104,10588-01-9,FGFR1,2260,sodium bichromate results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
SU 5402,C105686,,FGFR1,2260,SU 5402 results in decreased activity of FGFR1 protein,decreases^activity,3,1
SU 5402,C105686,,FGFR1,2260,SU 5402 results in decreased activity of FGFR1 protein mutant form,decreases^activity,1,1
sucrose octasulfate,C053081,57680-56-5,FGFR2,2263,sucrose octasulfate binds to FGFR2 protein,affects^binding,1,1
Sunitinib,D000077210,,FGFR1,2260,Sunitinib results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Suramin,D013498,145-63-1,FGFR2,2263,Suramin inhibits the reaction [FGF7 protein binds to FGFR2 protein],affects^binding|decreases^reaction,1,1
tamibarotene,C061133,94497-51-5,FGFR1,2260,tamibarotene results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Tamoxifen,D013629,10540-29-1,FGFR1,2260,FGFR1 protein results in decreased susceptibility to Tamoxifen,decreases^response to substance,1,1
Tamoxifen,D013629,10540-29-1,FGFR2,2263,FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Tamoxifen],decreases^reaction|decreases^response to substance,1,1
Tamoxifen,D013629,10540-29-1,FGFR2,2263,[Tamoxifen co-treated with ESR2 protein] results in decreased expression of FGFR2 mRNA,affects^cotreatment|decreases^expression,1,1
Taurine,D013654,107-35-7,FGFR1,2260,Taurine results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Testosterone,D013739,58-22-0,FGFR2,2263,[Testosterone co-treated with Calcitriol] results in increased expression of FGFR2 mRNA,affects^cotreatment|increases^expression,1,1
Testosterone,D013739,58-22-0,FGFR2,2263,Testosterone results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Tetrachlorodibenzodioxin,D013749,1746-01-6,FGFR1,2260,Tetrachlorodibenzodioxin results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Tetrachlorodibenzodioxin,D013749,1746-01-6,FGFR2,2263,Tetrachlorodibenzodioxin results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Tetrachlorodibenzodioxin,D013749,1746-01-6,FGFR2,2263,Tetrachlorodibenzodioxin results in increased expression of FGFR2 mRNA,increases^expression,1,1
Thalidomide,D013792,50-35-1,FGFR1,2260,Thalidomide affects the expression of FGFR1 mRNA,affects^expression,1,1
Thalidomide,D013792,50-35-1,FGFR2,2263,Thalidomide results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Thalidomide,D013792,50-35-1,FGFR2,2263,Thalidomide results in decreased expression of FGFR2 protein,decreases^expression,1,1
Thimerosal,D013849,54-64-8,FGFR2,2263,Thimerosal results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Thiram,D013893,137-26-8,FGFR1,2260,Thiram results in increased expression of FGFR1 mRNA,increases^expression,1,1
Thiram,D013893,137-26-8,FGFR2,2263,Thiram results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Tobacco Smoke Pollution,D014028,,FGFR1,2260,Tobacco Smoke Pollution affects the expression of FGFR1 mRNA,affects^expression,1,1
Tobacco Smoke Pollution,D014028,,FGFR2,2263,Tobacco Smoke Pollution results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Tobacco Smoke Pollution,D014028,,FGFR2,2263,Tobacco Smoke Pollution results in increased methylation of FGFR2 intron,increases^methylation,1,1
Tobacco Smoke Pollution,D014028,,FGFR2,2263,Tobacco Smoke Pollution results in increased methylation of FGFR2 promoter,increases^methylation,1,1
Tocopherols,D024505,,FGFR1,2260,Tocopherols results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Tretinoin,D014212,302-79-4,FGFR1,2260,Tretinoin affects the expression of FGFR1 mRNA,affects^expression,1,1
Tretinoin,D014212,302-79-4,FGFR1,2260,Tretinoin results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Tretinoin,D014212,302-79-4,FGFR2,2263,Tretinoin results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
"tris(1,3-dichloro-2-propyl)phosphate",C016805,13674-87-8,FGFR2,2263,"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of FGFR2 mRNA",decreases^expression,1,1
Urea,D014508,57-13-6,FGFR1,2260,Urea analog results in decreased activity of FGFR1 protein,decreases^activity,1,1
Urethane,D014520,51-79-6,FGFR1,2260,Urethane results in increased expression of FGFR1 mRNA,increases^expression,1,1
Valproic Acid,D014635,99-66-1,FGFR1,2260,Valproic Acid affects the expression of FGFR1 mRNA,affects^expression,1,1
Valproic Acid,D014635,99-66-1,FGFR1,2260,Valproic Acid results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Valproic Acid,D014635,99-66-1,FGFR1,2260,Valproic Acid results in increased expression of FGFR1 mRNA,increases^expression,1,1
Valproic Acid,D014635,99-66-1,FGFR1,2260,Valproic Acid results in increased methylation of FGFR1 gene,increases^methylation,1,1
Valproic Acid,D014635,99-66-1,FGFR2,2263,Valproic Acid affects the expression of FGFR2 mRNA,affects^expression,1,1
Valproic Acid,D014635,99-66-1,FGFR2,2263,Valproic Acid results in decreased expression of FGFR2 mRNA,decreases^expression,2,1
vanadyl sulfate,C034028,27774-13-6,FGFR2,2263,vanadyl sulfate results in increased expression of FGFR2 mRNA,increases^expression,1,1
vanillin,C100058,121-33-5,FGFR2,2263,vanillin results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Vehicle Emissions,D001335,,FGFR2,2263,Vehicle Emissions results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
Vehicle Emissions,D001335,,FGFR2,2263,[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of FGFR2 mRNA,increases^abundance|increases^expression,1,1
Vitamin K 3,D024483,58-27-5,FGFR2,2263,Vitamin K 3 affects the expression of FGFR2 mRNA,affects^expression,1,1
Volatile Organic Compounds,D055549,,FGFR1,2260,[Volatile Organic Compounds co-treated with Ozone] affects the expression of FGFR1 mRNA,affects^cotreatment|affects^expression,1,1
Vorinostat,D000077337,,FGFR1,2260,"[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FGFR1 mRNA",affects^cotreatment|decreases^expression,1,1
Vorinostat,D000077337,,FGFR1,2260,Vorinostat results in decreased expression of FGFR1 mRNA,decreases^expression,1,1
Vorinostat,D000077337,,FGFR2,2263,Vorinostat results in decreased expression of FGFR2 mRNA,decreases^expression,1,1
zinc protoporphyrin,C017803,15442-64-5,FGFR1,2260,[lead acetate co-treated with zinc protoporphyrin] results in increased expression of FGFR1 mRNA,affects^cotreatment|increases^expression,1,1
